Cambridge-based startup Mersana Therapeutics said today that it raised $75 million in an initial public offering. The company sold 5 million shares of common stock at $15 apiece. Mersana, which debuted on the Nasdaq exchange listed under “MRSN”, also gave underwriters a 30-day option to buy up to 750,000 more shares at $15 per share. […]
